Randox Biosciences has released its enhanced Respiratory Multiplex Array. Version II of the array provides comprehensive screening for infections of both the upper and lower respiratory tracts in four simple steps, extraction, amplification, hybridisation and detection on the Evidence Investigator imaging platform.
Utilising Randox’s innovative Biochip Array Technology, the array simultaneously detects 22 bacterial and viral pathogens from a single sputum, lavage or nasopharyngeal sample, reducing laboratory time and improving patient care.
The Randox Respiratory Array offers a number of benefits, including: superior multiplex polymerase chain reaction (PCR) testing (a cost-effective solution to detect a broad range of infections); single-sample, single-test approach for accurate multi‐pathogen diagnosis; simple, easy-to-interpret report generated in just under six hours; and reduced sample requirements.